Table 1

Clinical pathological data of cervical SCC patients (n = 77)
Cervical SCC patients Age (year) Selection date Clinical stage Differentai-ation degree Lymph node metastasis Tumor size (cm) LVSI HPV infection
1 46 2010.7.2 Stage I Well differentiation No ≤ 4 No Single/multiple HPV16 infection
2 44 2010.7.5 Stage II Moderate and poor differentiation No ≤ 4 No Single/multiple HPV16 infection
3 35 2010.7.13 Stage I Well differentiation No ≤ 4 Yes Negative
4 39 2010.7.26 Stage II Moderate and poor differentiation No ≤ 4 No Negative
5 38 2010.7.30 Stage I Moderate and poor differentiation Yes > 4 No Other HPV type
6 30 2010.8.2 Stage I Moderate and poor differentiation No ≤ 4 No Single/multiple HPV16 infection
7 47 2010.8.5 Stage III-IV Well differentiation Yes ≤ 4 No Single/multiple HPV16 infection
8 41 2010.8.12 Stage II Well differentiation No > 4 No Single/multiple HPV16 infection
9 44 2010.8.23 Stage II Moderate and poor differentiation No ≤ 4 No Negative
10 38 2010.8.23 Stage III-IV Moderate and poor differentiation No ≤ 4 No Other HPV type
11 27 2010.8.25 Stage III-IV Well differentiation No ≤ 4 No Other HPV type
12 48 2010.8.30 Stage I Moderate and poor differentiation No ≤ 4 No Negative
13 42 2010.9.7 Stage II Well differentiation Yes > 4 Yes Single/multiple HPV16 infection
14 44 2010.9.10 Stage I Moderate and poor differentiation No ≤ 4 No Negative
15 42 2010.9.17 Stage I Moderate and poor differentiation No > 4 No Single/multiple HPV16 infection
16 45 2010.9.27 Stage II Moderate and poor differentiation No > 4 No Single/multiple HPV16 infection
17 44 2010.9.28 Stage II Moderate and poor differentiation No 1 No Single/multiple HPV16 infection
18 42 2010.9.28 Stage II Moderate and poor differentiation No ≤ 4 No Other HPV type
19 47 2010.9.30 Stage II Moderate and poor differentiation Yes > 4 No Single/multiple HPV16 infection
20 39 2010.10.18 Stage I Moderate and poor differentiation No ≤ 4 No Single/multiple HPV16 infection
21 48 2010.10.28 Stage II Well differentiation No ≤ 4 No Single/multiple HPV16 infection
22 36 2010.11.2 Stage II Moderate and poor differentiation Yes > 4 Yes Other HPV type
23 43 2010.11.16 Stage II Moderate and poor differentiation No ≤ 4 No Other HPV type
24 34 2010.11.24 Stage I Moderate and poor differentiation No ≤ 4 No Other HPV type
25 46 2010.12.10 Stage III-IV Well differentiation --- > 4 --- Other HPV type
26 45 2010.12.16 Stage II Well differentiation --- ≤ 4 --- Other HPV type
27 32 2010.12.27 Stage III-IV Well differentiation --- ≤ 4 --- Single/multiple HPV16 infection
28 27 2011.1.7 Stage III-IV Well differentiation --- > 4 --- Single/multiple HPV16 infection
29 40 2011.1.14 Stage III-IV Well differentiation --- ≤ 4 --- Single/multiple HPV16 infection
30 29 2011.1.17 Stage III-IV Well differentiation --- ≤ 4 --- Other HPV type
31 42 2011.2.21 Stage I Well differentiation --- ≤ 4 --- Single/multiple HPV16 infection
32 35 2011.2.25 Stage I Well differentiation --- ≤ 4 --- Negative
33 29 2011.3.1 Stage III-IV Well differentiation --- > 4 --- Negative
34 38 2011.3.10 Stage III-IV Well differentiation --- ≤ 4 --- Other HPV type
35 41 2011.3.15 Stage III-IV Well differentiation --- ≤ 4 --- Single/multiple HPV16 infection
36 28 2011.3.19 Stage II Moderate and poor differentiation --- ≤ 4 --- Single/multiple HPV16 infection
37 40 2011.3.21 Stage II Moderate and poor differentiation --- > 4 --- Negative
38 37 2011.4.9 Stage II Moderate and poor differentiation --- ≤ 4 --- Other HPV type
39 43 2011.4.13 Stage II Moderate and poor differentiation --- > 4 --- Single/multiple HPV16 infection
40 29 2011.4.18 Stage II Well differentiation --- > 4 --- Other HPV type
41 43 2011.4.21 Stage II Moderate and poor differentiation --- > 4 --- Single/multiple HPV16 infection
42 53 2011.4.22 Stage III-IV Moderate and poor differentiation No > 4 Yes Negative
43 66 2011.5.10 Stage III-IV Moderate and poor differentiation No ≤ 4 No Other HPV type
44 54 2011.5.16 Stage III-IV Moderate and poor differentiation No ≤ 4 No Other HPV type
45 56 2011.5.23 Stage II Moderate and poor differentiation No ≤ 4 No Other HPV type
46 57 2011.5.25 Stage II Moderate and poor differentiation Yes ≤ 4 Yes Other HPV type
47 54 2011.5.30 Stage II Well differentiation No ≤ 4 No Other HPV type
48 54 2011.6.3 Stage III-IV Moderate and poor differentiation Yes ≤ 4 No Other HPV type
49 66 2011.6.10 Stage II Moderate and poor differentiation Yes ≤ 4 No Other HPV type
50 77 2011.6.14 Stage III-IV Moderate and poor differentiation Yes ≤ 4 No Single/multiple HPV16 infection
51 50 2011.6.15 Stage II Well differentiation No ≤ 4 No Single/multiple HPV16 infection
52 68 2011.6.20 Stage II Well differentiation No ≤ 4 No Negative
53 61 2011.7.11 Stage II Moderate and poor differentiation No ≤ 4 Yes Negative
54 69 2011.7.15 Stage II Moderate and poor differentiation No ≤ 4 Yes Other HPV type
55 49 2011.7.18 Stage II Moderate and poor differentiation No > 4 No Single/multiple HPV16 infection
56 49 2011.7.18 Stage II Moderate and poor differentiation Yes > 4 Yes Negative
57 54 2011.8.1 Stage II Moderate and poor differentiation No ≤ 4 No Single/multiple HPV16 infection
58 51 2011.8.25 Stage III-IV Well differentiation No ≤ 4 No Single/multiple HPV16 infection
59 56 2011.8.26 Stage II Moderate and poor differentiation Yes ≤ 4 Yes Single/multiple HPV16 infection
60 53 2011.913 Stage II Moderate and poor differentiation No > 4 No Single/multiple HPV16 infection
61 50 2011.9.16 Stage I Well differentiation No ≤ 4 No Other HPV type
62 51 2011.9.21 Stage II Moderate and poor differentiation No ≤ 4 No Single/multiple HPV16 infection
63 49 2011.9.23 Stage I Well differentiation No ≤ 4 No Negative
64 57 2011.10.14 Stage II Moderate and poor differentiation No ≤ 4 Yes Negative
65 61 2011.11.2 Stage II Well differentiation No > 4 No Other HPV type
66 52 2011.11.15 Stage II Moderate and poor differentiation No ≤ 4 No Negative
67 50 2011.11.17 Stage II Moderate and poor differentiation Yes > 4 No Single/multiple HPV16 infection
68 56 2011.11.21 Stage I Moderate and poor differentiation No ≤ 4 Yes Negative
69 64 2011.11.25 Stage I Moderate and poor differentiation No ≤ 4 No Single/multiple HPV16 infection
70 80 2011.12.2 Stage II Moderate and poor differentiation No ≤ 4 Yes Single/multiple HPV16 infection
71 61 2011.12.2 Stage II Well differentiation Yes ≤ 4 No Other HPV type
72 49 2011.12.5 Stage II Moderate and poor differentiation No > 4 No Other HPV type
73 49 2011.12.16 Stage II Moderate and poor differentiation Yes ≤ 4 No Other HPV type
74 59 2012.1.10 Stage II Moderate and poor differentiation Yes ≤ 4 No Other HPV type
75 50 2012.1.13 Stage II Moderate and poor differentiation Yes > 4 No Single/multiple HPV16 infection
76 67 2012.1.16 Stage I Moderate and poor differentiation No ≤ 4 Yes Other HPV type
77 58 2012.1.19 Stage III-IV Moderate and poor differentiation --- ≤ 4 --- Negative

Note: SCC, squamous cell carcinoma; LVSI, lymph vascular space invasion. “---” indicates that no such examination was performed.

Among the 77 cervical patients, 59 cases received extensive hysterectomy and pelvic lymphadenectomy and 18 cases were not treated with surgery. Lymph node metastasis and LVSI were not examined in these 18 cases who were not treated with surgery.

Chen et al.

Chen et al. Diagnostic Pathology 2014 9:88   doi:10.1186/1746-1596-9-88

Open Data